RE: RE: good or ok news?Excellent doesn't even do this justice.
To the doubters, ask yourself this, why on earth would the VP of development for a successful multinational drug company (whose stock is on fire to boot) actually go on record to state they are ramping up a PIIIb trial if in fact PIIIa isn't coming in at or above expectations.
There was no reason for them to issue this seed NR....they didn't have to provide an 'update' at all....frankly I'm not even sure they did...but they did and the message is clear....Urocidin works and thus they're setting up PIIIb, there isn't any other conclusion that can be drawn here...and I'm about as a negative a guy as you can get....